Publication | Open Access
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial
43
Citations
31
References
2020
Year
Our population PK and VEGF PD findings suggest a favorable ocular efficacy: systemic safety profile for ranibizumab in preterm infants.
| Year | Citations | |
|---|---|---|
Page 1
Page 1